Related Experiment Video
Updated: Jul 17, 2026

05:30
Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach
Published on: August 8, 2025
Hepatic hemangiomas: subtype classification and development of a clinical practice algorithm and registry
Emily R Christison-Lagay1, Patricia E Burrows, Ahmad Alomari
1Department of Surgery, Children's Hospital Boston, Boston, MA 02115, USA.
Journal of Pediatric Surgery
|January 9, 2007
Summary
Hepatic hemangiomas are categorized into focal, multifocal, and diffuse types, guiding treatment decisions. A new registry aims to improve understanding and management of these infant liver tumors.
Area of Science:
- Pediatric Hepatology
- Vascular Anomalies
- Radiology
Background:
- Hepatic hemangiomas, despite being benign, can cause severe infant morbidity and mortality.
- Existing literature lacks clarity on natural history and optimal treatment strategies.
- Clinical presentations vary widely, from asymptomatic lesions to life-threatening conditions like congestive heart failure and hepatic failure.
Purpose of the Study:
- To categorize hepatic hemangiomas based on radiologic and pathologic features.
- To establish a rational basis for selecting therapies according to lesion type and clinical presentation.
- To improve the management of infantile hepatic hemangiomas.
Main Methods:
- Retrospective analysis of radiologic and pathologic studies.
- Development of a classification system for hepatic hemangiomas.
- Creation of a clinical practice algorithm with international expert input.
Main Results:
- Proposed categorization of hepatic hemangiomas into three principal types: focal, multifocal, and diffuse.
- Recognition that different categories may respond variably to treatments.
- Establishment of a clinical practice algorithm for evaluation and management.
Conclusions:
- Categorization aids in predicting natural history and guiding therapy.
- A proposed international web-based registry will facilitate data collection and expert review.
- Further longitudinal studies are crucial for understanding treatment responses in these tumors.

